These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 21613357)
1. Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women. Broer SL; Eijkemans MJ; Scheffer GJ; van Rooij IA; de Vet A; Themmen AP; Laven JS; de Jong FH; Te Velde ER; Fauser BC; Broekmans FJ J Clin Endocrinol Metab; 2011 Aug; 96(8):2532-9. PubMed ID: 21613357 [TBL] [Abstract][Full Text] [Related]
2. Does anti-Müllerian hormone predict menopause in the general population? Results of a prospective ongoing cohort study. Depmann M; Eijkemans MJ; Broer SL; Scheffer GJ; van Rooij IA; Laven JS; Broekmans FJ Hum Reprod; 2016 Jul; 31(7):1579-87. PubMed ID: 27179263 [TBL] [Abstract][Full Text] [Related]
3. Anti-Mullerian hormone is a more accurate predictor of individual time to menopause than mother's age at menopause. Dólleman M; Depmann M; Eijkemans MJ; Heimensem J; Broer SL; van der Stroom EM; Laven JS; Van Rooij IA; Scheffer GJ; Peeters PH; van der Schouw YT; Lambalk CB; Broekmans FJ Hum Reprod; 2014 Mar; 29(3):584-91. PubMed ID: 24435779 [TBL] [Abstract][Full Text] [Related]
4. Added value of anti-Müllerian hormone in prediction of menopause: results from a large prospective cohort study. Dólleman M; Verschuren WM; Eijkemans MJ; Broekmans FJ; van der Schouw YT Hum Reprod; 2015 Aug; 30(8):1974-81. PubMed ID: 26082477 [TBL] [Abstract][Full Text] [Related]
5. The relationship between anti-Müllerian hormone in women receiving fertility assessments and age at menopause in subfertile women: evidence from large population studies. Dólleman M; Faddy MJ; van Disseldorp J; van der Schouw YT; Messow CM; Leader B; Peeters PH; McConnachie A; Nelson SM; Broekmans FJ J Clin Endocrinol Metab; 2013 May; 98(5):1946-53. PubMed ID: 23509105 [TBL] [Abstract][Full Text] [Related]
6. Anti-müllerian hormone is a promising predictor for the occurrence of the menopausal transition. van Rooij IA; Tonkelaar Id; Broekmans FJ; Looman CW; Scheffer GJ; de Jong FH; Themmen AP; te Velde ER Menopause; 2004; 11(6 Pt 1):601-6. PubMed ID: 15545787 [TBL] [Abstract][Full Text] [Related]
7. Back to the basics of ovarian aging: a population-based study on longitudinal anti-Müllerian hormone decline. de Kat AC; van der Schouw YT; Eijkemans MJ; Herber-Gast GC; Visser JA; Verschuren WM; Broekmans FJ BMC Med; 2016 Oct; 14(1):151. PubMed ID: 27716302 [TBL] [Abstract][Full Text] [Related]
8. The utility of measuring anti-Müllerian hormone in predicting menopause. Aydogan B; Mirkin S Climacteric; 2015; 18(6):777-89. PubMed ID: 25845388 [TBL] [Abstract][Full Text] [Related]
9. Antimüllerian hormone as predictor of reproductive outcome in subfertile women with elevated basal follicle-stimulating hormone levels: a follow-up study. Yarde F; Voorhuis M; Dólleman M; Knauff EA; Eijkemans MJ; Broekmans FJ Fertil Steril; 2013 Sep; 100(3):831-8. PubMed ID: 23755952 [TBL] [Abstract][Full Text] [Related]
10. Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle-stimulating hormone starting dose in in vitro fertilisation cycles. La Marca A; Papaleo E; Grisendi V; Argento C; Giulini S; Volpe A BJOG; 2012 Sep; 119(10):1171-9. PubMed ID: 22805536 [TBL] [Abstract][Full Text] [Related]
11. Modeling age at menopause using serum concentration of anti-mullerian hormone. Tehrani FR; Solaymani-Dodaran M; Tohidi M; Gohari MR; Azizi F J Clin Endocrinol Metab; 2013 Feb; 98(2):729-35. PubMed ID: 23316087 [TBL] [Abstract][Full Text] [Related]
12. Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women. Freeman EW; Sammel MD; Lin H; Gracia CR J Clin Endocrinol Metab; 2012 May; 97(5):1673-80. PubMed ID: 22378815 [TBL] [Abstract][Full Text] [Related]
13. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization. Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213 [TBL] [Abstract][Full Text] [Related]
14. Predictive markers for the FSH sensitivity of women with polycystic ovarian syndrome. Köninger A; Sauter L; Edimiris P; Kasimir-Bauer S; Kimmig R; Strowitzki T; Schmidt B Hum Reprod; 2014 Mar; 29(3):518-24. PubMed ID: 24419495 [TBL] [Abstract][Full Text] [Related]
15. Pretreatment serum anti-müllerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer. Anderson RA; Cameron DA J Clin Endocrinol Metab; 2011 May; 96(5):1336-43. PubMed ID: 21325458 [TBL] [Abstract][Full Text] [Related]
16. Individualized predictions of time to menopause using multiple measurements of antimüllerian hormone. Gohari MR; Ramezani Tehrani F; Chenouri S; Solaymani-Dodaran M; Azizi F Menopause; 2016 Aug; 23(8):839-45. PubMed ID: 27326817 [TBL] [Abstract][Full Text] [Related]
17. Anti-Müllerian hormone, follicle stimulating hormone, antral follicle count, and risk of menopause within 5 years. Kim C; Slaughter JC; Wang ET; Appiah D; Schreiner P; Leader B; Calderon-Margalit R; Sternfeld B; Siscovick D; Wellons M Maturitas; 2017 Aug; 102():18-25. PubMed ID: 28610678 [TBL] [Abstract][Full Text] [Related]
18. High frequency of discordance between antimüllerian hormone and follicle-stimulating hormone levels in serum from estradiol-confirmed days 2 to 4 of the menstrual cycle from 5,354 women in U.S. fertility centers. Leader B; Hegde A; Baca Q; Stone K; Lannon B; Seifer DB; Broekmans F; Baker VL Fertil Steril; 2012 Oct; 98(4):1037-42. PubMed ID: 22771028 [TBL] [Abstract][Full Text] [Related]
19. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients. Elgindy EA; El-Haieg DO; El-Sebaey A Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520 [TBL] [Abstract][Full Text] [Related]
20. Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials. Nelson SM; Klein BM; Arce JC Fertil Steril; 2015 Apr; 103(4):923-930.e1. PubMed ID: 25624196 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]